Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Period	PE Ratio
2016-12-31	1319.74
2017-12-31	501.50
2018-12-31	244.63
2019-12-31	179.75
2020-12-31	123.22
2021-12-31	99.11
2022-12-31	66.25
2023-12-31	54.51
2024-12-31	38.40

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$501.50	+0.00%	0.36M
3
4
5

Medpace Holdings Inc. (MEDP) PE Ratio

PE Ratio Data

Get Medpace Holdings Inc. Data in Excel

More MEDP Financial Data